Biotech company capital operations

Author: Luo Si
Publisher:
Publish Date: 2001-03-01
Features: Cynthia Robbins-Roth, a renowned biotechnology industry analyst, reveals the secrets of capital operations in biotechnology companies in this book. It describes the winding journey from startup to IPO of famous companies such as Amgen and Genentech, analyzes the internal management mechanisms and business models that can bring substantial profits, and points out the key factors for different biotechnology companies to achieve success. The book summarizes the application of both new and traditional financing methods in the biotechnology industry and provides a practical guide for investing in biotechnology stocks. The author weaves throughout the book her understanding of biotechnology and its development trends, as well as her grasp of the industry's growth patterns, using numerous case studies, data, and other first-hand materials to help readers better understand the unique capital operation rules and success experiences of biotechnology companies. For entrepreneurs, investors, and anyone interested in biotechnology, this book is invaluable. It nearly contains all the information needed to profit from the high-opportunity and high-risk investment sector of biotechnology.
Cynthia Robbins-Roth, a renowned biotechnology industry analyst, reveals the secrets of capital operations in biotechnology companies in this book. It describes the winding journey from startup to IPO of famous companies such as Amgen and Genentech, analyzes the internal management mechanisms and business models that can bring substantial profits, and points out the key factors for different biotechnology companies to achieve success. The book summarizes the application of both new and traditional financing methods in the biotechnology industry and provides a practical guide for investing in biotechnology stocks. The author weaves throughout the book her understanding of biotechnology and its development trends, as well as her grasp of the industry's growth patterns, using numerous case studies, data, and other first-hand materials to help readers better understand the unique capital operation rules and success experiences of biotechnology companies. For entrepreneurs, investors, and anyone interested in biotechnology, this book is invaluable. It nearly contains all the information needed to profit from the high-opportunity and high-risk investment sector of biotechnology.